Skip to content

Evaluation of a novel tablet-PC-based number connection test (eNCT)

Evaluation of a novel tablet-PC-based number connection test (eNCT) - eNCT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00009432
Enrollment
250
Registered
2015-10-15
Start date
2014-11-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K72.7

Interventions

Group 1: Reference Group: Applying Psychometric Hepatic Encephalopathy Score (PHES), Electronic Number Connection Test (eNCT) and StroopApp Test once or twice (after time interval). Group 2: Cirrhotic

Sponsors

Charité - Universitätsmedizin BerlinKlinik für Allgemein-, Visceral- und Transplantationschirurgie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. healty subjects (at least 18 years old) 2. patients (at least 18 years old) with histologically confirmed liver cirrhosis of every reasons (including alcoholic liver disease) or who are suspected to have liver cirrhosis because of existence of complications like ascites, varices, hepatic encephalopathy or increased part of connective tissue in the liver. 3. no florid abuse of alcohol or drugs in the last 6 months before study inclusion. 4. patients who gave there informed consent in written form

Exclusion criteria

Exclusion criteria: 1. mini-mental status score <25 2. known impairment of red and green vision 3. known neurological/psychiatric disease which affects the cognitive performance (besides hepatic encephalopathy) 4. knwon neurological/psychiatric disease with intake of medicine that affects the central nervous system (e.g. benzodiazepines or some sleeping pills)

Design outcomes

Primary

MeasureTime frame
test validity: correlation of the newly developed eNCT results with test times of well-established paper-pencil tests of the Psychometric Hepatic Encephalopathy Score test battery

Secondary

MeasureTime frame
test-retest-reliability; participants repeat the test procedure twice, with at least 4 days between the test and retest

Countries

Germany

Contacts

Public ContactTilo Wuensch

Klinik für Allgemein-, Visceral- und TransplantationschirurgieCharité Campus Virchow-Klinikum

tilo.wuensch@charite.de004930450652197

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026